{
    "info": {
        "Nasdaq_Traded": "Y",
        "Symbol": "ASMB",
        "Security_Name": "Assembly Biosciences, Inc. - Common Stock",
        "Listing_Exchange": "Q",
        "Market_Category": "Q",
        "ETF": "N",
        "Round_Lot_Size": "100.0",
        "Test_Issue": "N",
        "Financial_Status": "N",
        "CQS_Symbol": "",
        "NASDAQ_Symbol": "ASMB",
        "NextShares": "N"
    },
    "history": [],
    "recommendationTrend": {
        "trend": [
            {
                "period": "0m",
                "strongBuy": 0,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-1m",
                "strongBuy": 1,
                "buy": 2,
                "hold": 2,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-2m",
                "strongBuy": 1,
                "buy": 2,
                "hold": 2,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-3m",
                "strongBuy": 0,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            }
        ],
        "maxAge": 86400
    },
    "summaryDetail": {
        "maxAge": 1,
        "priceHint": 4,
        "previousClose": 1.4,
        "open": 1.45,
        "dayLow": 1.37,
        "dayHigh": 1.46,
        "regularMarketPreviousClose": 1.4,
        "regularMarketOpen": 1.45,
        "regularMarketDayLow": 1.37,
        "regularMarketDayHigh": 1.46,
        "payoutRatio": 0,
        "beta": 0.724392,
        "forwardPE": -0.4662162,
        "volume": 575908,
        "regularMarketVolume": 575908,
        "averageVolume": 282145,
        "averageVolume10days": 327320,
        "averageDailyVolume10Day": 327320,
        "bid": 1.39,
        "ask": 1.4,
        "bidSize": 2900,
        "askSize": 3000,
        "marketCap": 66049144,
        "fiftyTwoWeekLow": 0.82,
        "fiftyTwoWeekHigh": 2.42,
        "priceToSalesTrailing12Months": 10.561104,
        "fiftyDayAverage": 1.349,
        "twoHundredDayAverage": 1.7908,
        "currency": "USD",
        "fromCurrency": null,
        "lastMarket": null,
        "algorithm": null,
        "tradeable": false
    },
    "earnings": {
        "maxAge": 86400,
        "earningsChart": {
            "quarterly": [
                {
                    "date": "3Q2021",
                    "actual": -0.41,
                    "estimate": -0.56
                },
                {
                    "date": "4Q2021",
                    "actual": -0.38,
                    "estimate": -0.48
                },
                {
                    "date": "1Q2022",
                    "actual": -0.48,
                    "estimate": -0.47
                },
                {
                    "date": "2Q2022",
                    "actual": -0.51,
                    "estimate": -0.47
                }
            ],
            "currentQuarterEstimate": -0.47,
            "currentQuarterEstimateDate": "3Q",
            "currentQuarterEstimateYear": 2022,
            "earningsDate": [
                1678233600,
                1678665600
            ]
        },
        "financialsChart": {
            "yearly": [
                {
                    "date": 2018,
                    "revenue": 14804000,
                    "earnings": -90751000
                },
                {
                    "date": 2019,
                    "revenue": 15963000,
                    "earnings": -97634000
                },
                {
                    "date": 2020,
                    "revenue": 79105000,
                    "earnings": -62152000
                },
                {
                    "date": 2021,
                    "revenue": 6254000,
                    "earnings": -129855000
                }
            ],
            "quarterly": [
                {
                    "date": "3Q2021",
                    "revenue": 6254000,
                    "earnings": -18803000
                },
                {
                    "date": "4Q2021",
                    "revenue": 0,
                    "earnings": -60257000
                },
                {
                    "date": "1Q2022",
                    "revenue": 0,
                    "earnings": -23091000
                },
                {
                    "date": "2Q2022",
                    "revenue": 0,
                    "earnings": -24461000
                }
            ]
        },
        "financialCurrency": "USD"
    },
    "calendarEvents": {
        "maxAge": 1,
        "earnings": {
            "earningsDate": [
                1678233600,
                1678665600
            ],
            "earningsAverage": -0.47,
            "earningsLow": -0.54,
            "earningsHigh": -0.4
        }
    },
    "upgradeDowngradeHistory": {
        "history": [
            {
                "epochGradeDate": "2022-10-24T00:00:00.000Z",
                "firm": "Truist Securities",
                "toGrade": "Hold",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2022-04-01T00:00:00.000Z",
                "firm": "Truist Securities",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-09-13T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Neutral",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2021-09-02T00:00:00.000Z",
                "firm": "William Blair",
                "toGrade": "Market Perform",
                "fromGrade": "Outperform",
                "action": "down"
            },
            {
                "epochGradeDate": "2021-05-10T00:00:00.000Z",
                "firm": "SVB Leerink",
                "toGrade": "Market Perform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-03-23T00:00:00.000Z",
                "firm": "SVB Leerink",
                "toGrade": "Market Perform",
                "fromGrade": "Outperform",
                "action": "down"
            },
            {
                "epochGradeDate": "2020-11-06T00:00:00.000Z",
                "firm": "Jefferies",
                "toGrade": "Hold",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2020-10-19T00:00:00.000Z",
                "firm": "Truist Securities",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2020-07-08T00:00:00.000Z",
                "firm": "SVB Leerink",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2019-10-16T00:00:00.000Z",
                "firm": "Mizuho",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2018-10-08T00:00:00.000Z",
                "firm": "B. Riley Securities",
                "toGrade": "Buy",
                "fromGrade": "Neutral",
                "action": "up"
            },
            {
                "epochGradeDate": "2018-08-08T00:00:00.000Z",
                "firm": "Baird",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2018-05-08T00:00:00.000Z",
                "firm": "B. Riley Securities",
                "toGrade": "Neutral",
                "fromGrade": "Neutral",
                "action": "main"
            },
            {
                "epochGradeDate": "2018-04-13T00:00:00.000Z",
                "firm": "Chardan Capital",
                "toGrade": "Neutral",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2018-01-05T00:00:00.000Z",
                "firm": "B. Riley Securities",
                "toGrade": "Neutral",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2017-11-08T00:00:00.000Z",
                "firm": "Jefferies",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            }
        ],
        "maxAge": 86400
    },
    "price": {
        "maxAge": 1,
        "preMarketSource": "FREE_REALTIME",
        "regularMarketChangePercent": -0.014285701,
        "regularMarketChange": -0.01999998,
        "regularMarketTime": "2023-01-06T21:00:04.000Z",
        "priceHint": 4,
        "regularMarketPrice": 1.38,
        "regularMarketDayHigh": 1.46,
        "regularMarketDayLow": 1.37,
        "regularMarketVolume": 575908,
        "averageDailyVolume10Day": 327320,
        "averageDailyVolume3Month": 282145,
        "regularMarketPreviousClose": 1.4,
        "regularMarketSource": "FREE_REALTIME",
        "regularMarketOpen": 1.45,
        "exchange": "NMS",
        "exchangeName": "NasdaqGS",
        "exchangeDataDelayedBy": 0,
        "marketState": "CLOSED",
        "quoteType": "EQUITY",
        "symbol": "ASMB",
        "underlyingSymbol": null,
        "shortName": "Assembly Biosciences, Inc.",
        "longName": "Assembly Biosciences, Inc.",
        "currency": "USD",
        "quoteSourceName": "Delayed Quote",
        "currencySymbol": "$",
        "fromCurrency": null,
        "lastMarket": null,
        "marketCap": 66049144
    },
    "defaultKeyStatistics": {
        "maxAge": 1,
        "priceHint": 4,
        "enterpriseValue": -32168516,
        "forwardPE": -0.82634735,
        "profitMargins": 0,
        "floatShares": 44239824,
        "sharesOutstanding": 47861700,
        "sharesShort": 1485255,
        "sharesShortPriorMonth": 1357892,
        "sharesShortPreviousMonthDate": 1663200000,
        "dateShortInterest": 1665705600,
        "sharesPercentSharesOut": 0.0307,
        "heldPercentInsiders": 0.01543,
        "heldPercentInstitutions": 0.35105,
        "shortRatio": 6.79,
        "shortPercentOfFloat": 0.031,
        "beta": 0.724392,
        "category": null,
        "bookValue": 7.07,
        "priceToBook": 0.19519094,
        "fundFamily": null,
        "legalType": null,
        "lastFiscalYearEnd": "2021-12-31T00:00:00.000Z",
        "nextFiscalYearEnd": "2023-12-31T00:00:00.000Z",
        "mostRecentQuarter": "2022-06-30T00:00:00.000Z",
        "netIncomeToCommon": -126612000,
        "trailingEps": -1.754,
        "forwardEps": -2.96,
        "pegRatio": -0.05,
        "lastSplitFactor": "1:5",
        "lastSplitDate": "2014-07-14T00:00:00.000Z",
        "enterpriseToRevenue": -5.144,
        "enterpriseToEbitda": 0.382
    },
    "summaryProfile": {
        "address1": "331 Oyster Point Boulevard",
        "address2": "Fourth Floor",
        "city": "South San Francisco",
        "state": "CA",
        "zip": "94080",
        "country": "United States",
        "phone": "833 509 4583",
        "website": "https://www.assemblybio.com",
        "industry": "Biotechnology",
        "sector": "Healthcare",
        "longBusinessSummary": "Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. It also has strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.",
        "fullTimeEmployees": 70,
        "companyOfficers": [],
        "maxAge": 86400
    },
    "financialData": {
        "maxAge": 86400,
        "currentPrice": 1.38,
        "targetHighPrice": 15,
        "targetLowPrice": 2,
        "targetMeanPrice": 7.1,
        "targetMedianPrice": 2.5,
        "recommendationMean": 2.4,
        "recommendationKey": "buy",
        "numberOfAnalystOpinions": 5,
        "totalCash": 116689000,
        "totalCashPerShare": 2.409,
        "ebitda": -84129504,
        "totalDebt": 5084000,
        "quickRatio": 7.835,
        "currentRatio": 8.308,
        "totalRevenue": 6254000,
        "debtToEquity": 4.101,
        "revenuePerShare": 0.134,
        "returnOnAssets": -0.26076,
        "returnOnEquity": -0.71175003,
        "grossProfits": 5706000,
        "freeCashflow": -46194312,
        "operatingCashflow": -83631000,
        "grossMargins": 1.69683,
        "ebitdaMargins": 0,
        "operatingMargins": -13.5287,
        "profitMargins": 0,
        "financialCurrency": "USD"
    }
}